Literature DB >> 14527085

Mechanisms of viral hepatitis induced liver injury.

Yasunari Nakamoto1, Shuichi Kaneko.   

Abstract

Among seven human hepatitis viruses (A to E, G and TT virus), hepatitis B (HBV) and C (HCV) viruses are able to persist in the host for years and principally contribute to the establishment of chronic hepatitis. During the course of persistent infection, continuous intrahepatic inflammation maintains a cycle of liver cell destruction and regeneration that often terminates in hepatocellular carcinoma (HCC). While the expression and retention of viral proteins in hepatocytes may influence the severity and progression of liver disease, the mechanisms of liver injury in viral hepatistis are defined to be due not to the direct cytopathic effects of viruses, but to the host immune response to viral proteins expressed by infected hepatocytes. In the process of liver injury, hepatocellular death (apoptosis) induced by the proapoptotic molecules of T cells activated following antigen recognition triggers a cascade of antigen nonspecific effector systems and causes necroinflammatory disease. Accordingly, the regulation of the immune response, e.g., via the cell death pathways, in chronically infected patients should prevent the development of HCC.

Entities:  

Mesh:

Year:  2003        PMID: 14527085     DOI: 10.2174/1566524033479591

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  23 in total

1.  Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1.

Authors:  Chan Gyu Lee; Young Woo Kim; Eun Hyun Kim; Zhipeng Meng; Wendong Huang; Se Jin Hwang; Sang Geon Kim
Journal:  Gastroenterology       Date:  2012-01-18       Impact factor: 22.682

Review 2.  NF-κB and STAT3 - key players in liver inflammation and cancer.

Authors:  Guobin He; Michael Karin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

Review 3.  Hepatocyte polarity.

Authors:  Aleksandr Treyer; Anne Müsch
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

4.  Hepatic tight junctions: from viral entry to cancer metastasis.

Authors:  Nikki P Lee; John M Luk
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

5.  Association of the -183 polymorphism in the IFN-gamma gene promoter with hepatitis B virus infection in the Chinese population.

Authors:  Suxia Qi; Bangwei Cao; Mingwei Jiang; Changqing Xu; Yue Dai; Kun Li; Kun Wang; Yang Ke; Tao Ning
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

6.  The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice.

Authors:  Keren Bitton-Worms; Eli Pikarsky; Ami Aronheim
Journal:  Mol Cancer       Date:  2010-03-09       Impact factor: 27.401

7.  Effect of seasonal variation on the clinical course of chronic hepatitis B.

Authors:  Shi-Jun Zhang; Ze-Xiong Chen; Kai-Ping Jiang; Wei-Kang Wu; Cui-Yi Zhang; Yan-Li Gu
Journal:  J Gastroenterol       Date:  2006-12-08       Impact factor: 7.527

8.  Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.

Authors:  William O Osburn; Melinda S Yates; Patrick D Dolan; Sining Chen; Karen T Liby; Michael B Sporn; Keiko Taguchi; Masayuki Yamamoto; Thomas W Kensler
Journal:  Toxicol Sci       Date:  2008-04-15       Impact factor: 4.849

Review 9.  Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis.

Authors:  Erzsébet Szabó; Csilla Páska; Pál Kaposi Novák; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

Review 10.  Chemotherapy: a double-edged sword in cancer treatment.

Authors:  Nafiseh Behranvand; Farzad Nasri; Reza Zolfaghari Emameh; Pouria Khani; Asieh Hosseini; Johan Garssen; Reza Falak
Journal:  Cancer Immunol Immunother       Date:  2021-08-05       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.